LBL ICBP50 integrative genomic data
13 Nov 2014 | Downloads | Contributor(s): Joe Gray, Jonathan Bistline
From Joe Gray, Lawrence Berkeley National Laboratory. There are seventeen (17) files in this study: Affymetrix U133A gene expression data (icbp_u133a.gct) Affymetrix U133A gene expression data (ICBP_U133a.zip) Affymetrix splice junction exon-exon data (ICBP_Junction.zip) Affymetrix...
Baylor Residual breast cancer
13 Nov 2014 | Downloads | Contributor(s): Creighton C, Lewis M, Chang J, Jonathan Bistline
Residual breast cancers after conventional therapy display mesenchymal as tumor-initiating features. There are four (4) files included in this study: Sample Annotation (combined_sample_annotation.txt) Gene expression data from CD44+/CD24- cells sorted by flow cytometry (GSE7513.gct) Human...
Overview of the National Cancer Institute (NCI) Nanotechnology Characterizaton Laboratory (NCL)
03 Nov 2014 | Presentations | Contributor(s): Jennifer Hall Grossman
Working in concert with the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI) established the Nanotechnology Characterization Laboratory to perform preclinical efficacy and toxicity testing of...
caNanoLab Data Portal Presentation
25 Sep 2014 | Presentations | Contributor(s): Sharon Gaheen
caNanoLab is a data sharing portal designed to facilitate information sharing across the international biomedical nanotechnology research community to expedite and validate the use of nanotechnology in biomedicine. caNanoLab provides support for the annotation of nanomaterials with...
Integrated analysis of breast cancer cell lines reveals unique signaling pathways
16 Sep 2014 | Publications | Contributor(s): Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray, Paul T Spellman
AbstractBackgroundCancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which...
Environmental Consequences of Nanotechnologies
11 Sep 2014 | Presentations | Contributor(s): Jeffrey Steevens, Alan Kennedy, Jessica Coleman, Zach Collier, Aimee Poda, Charles Weiss, Mark Widder, Jonathan Stallings, Robert Moser
Jeffery A Steevens, Senior ScientistAlan Kennedy, Jessica Coleman, Zach Collier, Robert Moser, Aimee Poda, Charles WeissUS Army ERDCMark Widder and MAJ Jonathan StallingsUS Army Center for Environmental Health ResearchPresentation to NCI - Nanotechnology Working Group 11 September 2014
Considerations of relevance vs reliability and know vs show for CLEAR communication and how they relate to issues for nanotechnology, including the data-readiness levels
09 Sep 2014 | Presentations | Contributor(s): Stacey L Harper, Mark D Hoover
Presentation for the Nano WG 4.24. 2014
13 Aug 2014 | Teaching Materials | Contributor(s): Lisa E Friedersdorf
Nanotechnology Signature InitiativeNanotechnology Knowledge Infrastructure (NKI):Enabling National Leadership in Sustainable DesignDraft Discussion Document: May 9, 2013
Nanocuration update by Christine Hendren
02 Jun 2014 | Presentations | Contributor(s): Christine Ogilvie Hendren
Nanocuration update by Christine Hendren, Nano WG May 29, 2014